Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application

Launched by DARTMOUTH-HITCHCOCK MEDICAL CENTER · May 17, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating a new way to help people with epilepsy through a web-based music application. Specifically, it aims to see if listening to music can have a positive effect on adults with a type of epilepsy called refractory focal epilepsy, which means their seizures are not well controlled by medication. The study will be done at home, where participants will use the music application on their personal devices.

To be eligible for the trial, participants need to be adults aged 65 to 74 who have had a special device called a Responsive Neurostimulator (RNS) implanted for at least six months, and their doctor considers their RNS treatment stable. Participants will need to attend study visits and have access to the internet. It’s important to note that individuals with a specific type of seizure triggered by music cannot join the study. This trial is not yet recruiting, but it aims to gather valuable information on how this innovative music therapy could help manage epilepsy.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Adults with medication-refractory focal epilepsy who have undergone RNS implantation at least six months prior and are in the judgement of the treating physician on a stable RNS regimen in terms of stimulation
• • Willing to attend all study visits and complete all required study procedures
• • Access to private or public wireless data service at regular intervals
• • Access to personal mobile device
• Exclusion Criteria:
• • Documentation of a musicogenic, or auditory-triggered focal seizure semiology
• • Participant is unable to reasonably participate in study tasks as determined by the investigator
• • Inability to obtain informed consent from the patient or legally authorized representative